KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeExpense - Real EstateGross ProfitIncome from Non-Controlling InterestsNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for National Health Investors (NHI) over the last 14 years, with Jun 2025 value amounting to $36.9 million.

  • National Health Investors' Net Income towards Common Stockholders rose 4.86% to $36.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $142.8 million, marking a year-over-year increase of 11.98%. This contributed to the annual value of $137.9 million for FY2024, which is 1.67% up from last year.
  • As of Q2 2025, National Health Investors' Net Income towards Common Stockholders stood at $36.9 million, which was up 8.28% from $34.1 million recorded in Q1 2025.
  • In the past 5 years, National Health Investors' Net Income towards Common Stockholders registered a high of $43.2 million during Q4 2024, and its lowest value of $1.9 million during Q4 2022.
  • Over the past 3 years, National Health Investors' median Net Income towards Common Stockholders value was $34.3 million (recorded in 2023), while the average stood at $34.5 million.
  • Within the past 5 years, the most significant YoY rise in National Health Investors' Net Income towards Common Stockholders was 1,619.11% (2023), while the steepest drop was 14.92% (2023).
  • Quarterly analysis of 4 years shows National Health Investors' Net Income towards Common Stockholders stood at $1.9 million in 2022, then soared by 1,619.11% to $32.0 million in 2023, then skyrocketed by 34.93% to $43.2 million in 2024, then grew by 4.86% to $36.9 million in 2025.
  • Its Net Income towards Common Stockholders stands at $36.9 million for Q2 2025, versus $34.1 million for Q1 2025 and $43.2 million for Q4 2024.